InVivo Therapeutics Announces $3.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules – Business Wire / Common Stock Warrants, US Warrant News / By https://commonstockwarrants.com InVivo Therapeutics Announces $3.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules Business Wire